Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 21

    1.

    Acute radiation injury: contingency planning for triage, supportive care, and transplantation.

    Weisdorf D, Chao N, Waselenko JK, Dainiak N, Armitage JO, McNiece I, Confer D.

    Biol Blood Marrow Transplant. 2006 Jun;12(6):672-82. Review.PMID: 16737941 [PubMed - indexed for MEDLINE]Related articles

    2.

    A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma.

    Willis CR, Goodrich A, Park K, Waselenko JK, Lucas M, Reese A, Diehl LF, Grever MR, Byrd JC, Flinn IW.

    Ann Hematol. 2006 May;85(5):301-7. Epub 2006 Mar 4.PMID: 16518606 [PubMed - indexed for MEDLINE]Related articles

    3.

    Medical management of radiological casualties.

    Goans RE, Waselenko JK.

    Health Phys. 2005 Nov;89(5):505-12.PMID: 16217194 [PubMed - indexed for MEDLINE]Related articles

    4.

    Medical management of patients with multiple organ dysfunction arising from acute radiation syndrome.

    Jackson WL Jr, Gallagher C, Myhand RC, Waselenko JK.

    BJR Suppl. 2005;27:161-8.PMID: 15975890 [PubMed - in process]Related articles

    5.

    Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group.

    Waselenko JK, MacVittie TJ, Blakely WF, Pesik N, Wiley AL, Dickerson WE, Tsu H, Confer DL, Coleman CN, Seed T, Lowry P, Armitage JO, Dainiak N; Strategic National Stockpile Radiation Working Group.

    Ann Intern Med. 2004 Jun 15;140(12):1037-51.PMID: 15197022 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Thrombotic microangiopathy (TMA) and stroke due to human herpesvirus-6 (HHV-6) reactivation in an adult receiving high-dose melphalan with autologous peripheral stem cell transplantation.

    Belford A, Myles O, Magill A, Wang J, Myhand RC, Waselenko JK.

    Am J Hematol. 2004 Jun;76(2):156-62.PMID: 15164383 [PubMed - indexed for MEDLINE]Related articles

    7.

    The hematologist and radiation casualties.

    Dainiak N, Waselenko JK, Armitage JO, MacVittie TJ, Farese AM.

    Hematology Am Soc Hematol Educ Program. 2003:473-96. Review.PMID: 14633795 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Post-transplant interleukin-2 in patients with low-grade lymphoid neoplasms previously treated with fludarabine is limited by hematologic toxicity.

    Waselenko JK, Burrows A, Nelson DA, Lucas M, Ekstrand J, Edenfield WJ, Myhand RC.

    Ann Hematol. 2003 Sep;82(9):552-7. Epub 2003 Aug 9.PMID: 12910372 [PubMed - indexed for MEDLINE]Related articles

    9.

    Carboxyamido-triazole (CAI)--a novel "static" signal transduction inhibitor induces apoptosis in human B-cell chronic lymphocytic leukemia cells.

    Waselenko JK, Shinn CA, Willis CR, Flinn IW, Grever MR, Byrd JC.

    Leuk Lymphoma. 2001 Sep-Oct;42(5):1049-53.PMID: 11697622 [PubMed - indexed for MEDLINE]Related articles

    10.

    Gemcitabine demonstrates in vitro activity against human B-cell chronic lymphocytic leukemia.

    Waselenko JK, Grever MR, Shinn CA, Flinn IW, Byrd JC.

    Leuk Res. 2001 Jun;25(6):435-40.PMID: 11337014 [PubMed - indexed for MEDLINE]Related articles

    11.

    Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity.

    Byrd JC, Murphy T, Howard RS, Lucas MS, Goodrich A, Park K, Pearson M, Waselenko JK, Ling G, Grever MR, Grillo-Lopez AJ, Rosenberg J, Kunkel L, Flinn IW.

    J Clin Oncol. 2001 Apr 15;19(8):2153-64.PMID: 11304767 [PubMed - indexed for MEDLINE]Related articles

    12.

    Novel therapies for chronic lymphocytic leukemia in the 21st century.

    Byrd JC, Waselenko JK, Keating M, Rai K, Grever MR.

    Semin Oncol. 2000 Oct;27(5):587-97. Review.PMID: 11049025 [PubMed - indexed for MEDLINE]Related articles

    14.

    Theophylline, pentostatin (Nipent), and chlorambucil: a dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disorders.

    Byrd JC, Grever MR, Waselenko JK, Willis CR, Park K, Goodrich A, Lucas MA, Shinn C, Flinn IW.

    Semin Oncol. 2000 Apr;27(2 Suppl 5):37-40.PMID: 10877050 [PubMed - indexed for MEDLINE]Related articles

    15.

    Depsipeptide (FR901228): a novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells.

    Byrd JC, Shinn C, Ravi R, Willis CR, Waselenko JK, Flinn IW, Dawson NA, Grever MR.

    Blood. 1999 Aug 15;94(4):1401-8. Erratum in: Blood 2000 Jan 15;95(2):409. PMID: 10438728 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Preservation of nucleic acids for polymerase chain reaction after prolonged storage at room temperature.

    Tuttle RM, Waselenko JK, Yosseffi P, Weigand N, Martin RK.

    Diagn Mol Pathol. 1998 Dec;7(6):302-9.PMID: 10207668 [PubMed - indexed for MEDLINE]Related articles

    17.

    Stem-cell transplantation in chronic lymphocytic leukemia: the time for designing randomized studies has arrived.

    Waselenko JK, Flynn JM, Byrd JC.

    Semin Oncol. 1999 Feb;26(1):48-61. Review.PMID: 10073561 [PubMed - indexed for MEDLINE]Related articles

    18.

    Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: association with increased infusion-related side effects and rapid blood tumor clearance.

    Byrd JC, Waselenko JK, Maneatis TJ, Murphy T, Ward FT, Monahan BP, Sipe MA, Donegan S, White CA.

    J Clin Oncol. 1999 Mar;17(3):791-5.PMID: 10071268 [PubMed - indexed for MEDLINE]Related articles

    19.

    Women with thrombophilia: assessing the risks for thrombosis with oral contraceptives or hormone replacement therapy.

    Waselenko JK, Nace MC, Alving B.

    Semin Thromb Hemost. 1998;24 Suppl 1:33-9. Review.PMID: 9840690 [PubMed - indexed for MEDLINE]Related articles

    20.

    Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53.

    Byrd JC, Shinn C, Waselenko JK, Fuchs EJ, Lehman TA, Nguyen PL, Flinn IW, Diehl LF, Sausville E, Grever MR.

    Blood. 1998 Nov 15;92(10):3804-16.PMID: 9808574 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Management of progressive metastatic prostate cancer.

    Waselenko JK, Dawson NA.

    Oncology (Williston Park). 1997 Oct;11(10):1551-60; discussion 1560-3, 1567-8.PMID: 9348559 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...